Method of detecting the presence and/or progression of cancer
OwnerStephen Websterinventor
Life of this patent
Estimating the term…
Abstract
Silver (II) Oxide preferentially reacts with tNOX a cancer-specific ECTO-NOX protein of the surface of cancer cells. The combination of the cancer specificity of tNOX and the interaction of silver II oxide specified herein with tNOX offer new and novel therapeutic and diagnostic opportunities including but not restricted to coupling with one or more commercially available silver enhancement protocols for cancer detection as well as detection of an age-related ECTO-NOX form, designated ar-NOX.
Claims35
A method of detecting the presence of cancer comprising:
- providing a sample from a patient;
- providing silver (II) oxide to the sample;
- determining the presence of color in the sample.
A method of detecting the presence of cancer comprising:
- obtaining serum from a patient;
- contacting the serum with silver (II) oxide to form a mixture;
- and
- determining the presence of color in the mixture.
An assay for detecting or monitoring abnormal cellular proliferation comprising:
- silver (II) oxide.
A method of detecting the presence of cancer comprising:
- obtaining a sample from a patient;
- contacting the sample with silver (II) oxide;
- and
- detecting binding of the silver (II) oxide to a cancer-associated protein.
A method of measuring the progression of cancer comprising:
- obtaining a sample;
- contacting the sample with silver (III) oxide;
- and
- detecting the binding of silver (II) oxide to arNOX.
A method of assaying cancer cells in vivo comprising:
- administering silver (II) oxide bound to magnetic beads to a subject;
- and
- detecting the magnetic beads.
Dependencies are inferred from the claim text.